Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2008-07-29
2008-07-29
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C546S139000, C546S275700
Reexamination Certificate
active
07405299
ABSTRACT:
The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
REFERENCES:
patent: 7087626 (2006-08-01), Beight et al.
patent: 2006/0040983 (2006-02-01), Beight et al.
patent: 2006/0079680 (2006-04-01), Sawyer
patent: WO 02 062787 (2002-08-01), None
patent: WO 02 062794 (2002-08-01), None
patent: WO 02 066462 (2002-08-01), None
patent: 2002094833 (2002-11-01), None
patent: WO 02 094833 (2002-11-01), None
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, pp. 1-6.
Dermer (Bio/Technology, 1994, 12:320).
Beight Douglas Wade
Burkholder Timothy Paul
Decollo Todd Vincent
Diefenbacher Clive Gideon
Engler Thomas Albert
Eli Lilly and Company
Hostettler Danica
Rahmani Niloofar
Seaman D. Margaret
Tucker Tina M.
LandOfFree
Compounds as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds as pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2743214